Home > Boards > US Listed > Medical - Drugs >

PROTALIX BIOTHERAPEUTICS, INC. (PLX)

PLX RSS Feed
Add PLX Price Alert      Hide Sticky   Hide Intro
Moderator: midastouch017, king oil
Search This Board: 
Last Post: 5/9/2021 8:22:24 AM - Followers: 110 - Board type: Free - Posts Today: 2

(PLX)Market Cap $38 M--Cash $21 M -- 1 Drug launched for the treatment of Gaucher disease partnered with Pfizer -- Next Drug a potential Blockbuster for the treatment of Fabry disease close to BLA filing expected in April with potential FDA approval 6 months later .Brutally undervalued low float stock with MASSIVE upside potential could hit $15-20 next year .STRONG BUY

Protalix (PLX)
Market Cap: $38 Million
Cash $21 Million

Shares Out 14.8 Million



Presentation
https://protalixbiotherapeutics.gcs-web.com/static-files/a455e93c-dc37-4422-a3be-8c869df48e21


Protalix BioTherapeutics and Chiesi Farmaceutici Announce Successful pre-BLA Meeting with FDA for Accelerated Approval of pegunigalsidase alfa for the Treatment of Fabry Disease in the United States
https://finance.yahoo.com/news/protalix-biotherapeutics-chiesi-farmaceutici-announce-115000421.html


Company Highlights


Big Dealwith Chiesi


Potential to be gold standard therapy ( $1+ BILLION peak Sales)


 
 

Protalix BioTherapeutics, a biopharmaceutical company, focuses on the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in Israel and internationally. The company offers Elelyso, a plant cell expressed recombinant glucocerebrosidase enzyme for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in phase III clinical trials for the treatment of Fabry diseases; OPRX-106, an orally-delivered protein product candidate for the treatment of inflammatory bowel disease, as well as completed Phase IIa clinical trial for ulcerative colitis patients; PRX-110, a proprietary plant cell recombinant form of human deoxyribonuclease I that has completed phase IIa clinical trials for the treatment of cystic fibrosis; and PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. Protalix BioTherapeutics was founded in 1993 and is headquartered in Karmiel, Israel.
PLX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PLX News: Amended Annual Report (10-k/a) 04/30/2021 06:44:46 AM
PLX News: Protalix Bio slides on FDA rejection of experimental therapy for Fabry disease 04/28/2021 06:49:02 AM
PLX News: Current Report Filing (8-k) 04/28/2021 06:08:21 AM
PLX News: Protalix BioTherapeutics stock up after FY revenue beat 03/30/2021 08:18:38 AM
PLX News: Annual Report (10-k) 03/30/2021 07:40:11 AM
PostSubject
#3511  Sticky Note Protalix BioTherapeutics and Chiesi Global Rare Diseases Receive midastouch017 04/28/21 04:38:19 AM
#3552   The list goes on: SLGL PDUFA 27 APR, midastouch017 05/09/21 08:22:24 AM
#3551   Two days ago, the UK put Israel on Spideyboy 05/09/21 07:46:13 AM
#3550   Protalix BioTherapeutics to Hold First Quarter 2021 Financial midastouch017 05/07/21 11:38:47 AM
#3549   A CRL. What a difficult slap-in-the-face to patients, wgg2 05/03/21 02:06:51 PM
#3548   RIH $PLX Foxxycleopatra 04/30/21 06:17:44 AM
#3547   Out of curiosity, does anyone know how many skitahoe 04/29/21 05:18:25 PM
#3546   Criminal really jcon777 04/29/21 04:39:10 PM
#3545   Criminal really Kronberg 04/29/21 03:45:10 PM
#3544   Criminal really Tex18 04/29/21 12:40:14 PM
#3543   Patients suffer and the FDA doesn’t give a king oil 04/29/21 12:39:40 PM
#3542   What a giant crock of shit from the Tex18 04/29/21 12:29:19 PM
#3541   FDA CRLs Have Become Common jcon777 04/29/21 12:22:04 PM
#3540   I think it makes it more difficult for king oil 04/29/21 11:33:15 AM
#3539   Fabrazyme recently gets full approval jcon777 04/29/21 10:49:39 AM
#3538   I think the FDA is covering their bbhuey 04/29/21 09:56:27 AM
#3537   We have more confidence the midastouch017 04/29/21 08:19:36 AM
#3536   Thx Spidey. On the positive side: jcon777 04/29/21 08:13:52 AM
#3535   I took a big hit as well, but skitahoe 04/29/21 02:32:13 AM
#3534   Agreed it's very annoying to say the least. Guzzi62 04/28/21 11:46:48 PM
#3533   Management is not in control of PDUFA date Spideyboy 04/28/21 10:59:37 PM
#3532   * * $PLX Video Chart 04-28-2021 * * ClayTrader 04/28/21 06:07:04 PM
#3531   Embarrassing for FDA & Management jcon777 04/28/21 02:34:44 PM
#3530   Think you’re correct, which isn’t that what balance Tex18 04/28/21 02:33:10 PM
#3529   Protalix Bio says FDA rejection for PRX–102 was Tex18 04/28/21 02:32:24 PM
#3528   Update: apparently the CRL is due to king oil 04/28/21 01:50:49 PM
#3527   I agree..."The recent dilution so close to the conix 04/28/21 01:11:01 PM
#3526   I never saw any issues with the clinical king oil 04/28/21 12:40:17 PM
#3525   You are kidding Mr Conix. I wonder what Kronberg 04/28/21 10:31:48 AM
#3524   I was considering PLX a couple of months conix 04/28/21 09:56:53 AM
#3523   ST Livingthedreamtx post 22m maybe this is the reason Kronberg 04/28/21 09:45:14 AM
#3522   Yes, the dilution and ATM sale before the Kronberg 04/28/21 08:34:23 AM
#3521   Lots of posts on Stocktwits that it will king oil 04/28/21 08:17:02 AM
#3520   Now we know why they diluted so close king oil 04/28/21 07:04:23 AM
#3519   Interesting, this article also shows outsourced manufacturing as Spideyboy 04/28/21 06:57:52 AM
#3518   Hoping for manufacturing issues: jcon777 04/28/21 06:27:36 AM
#3517   One small addition to my earlier post regarding Spideyboy 04/28/21 06:20:46 AM
#3516   RIP PLX king oil 04/28/21 06:04:18 AM
#3515   Reading into the Terminology of the Press Release Spideyboy 04/28/21 05:51:25 AM
#3514   From the PR: midastouch017 04/28/21 05:34:30 AM
#3513   If balance data is good ... jcon777 04/28/21 04:56:35 AM
#3512   I feel like saying this makes no sense. Spideyboy 04/28/21 04:56:34 AM
#3511   Protalix BioTherapeutics and Chiesi Global Rare Diseases Receive midastouch017 04/28/21 04:38:19 AM
#3510   Well now we know, CRL and issues to fix Spideyboy 04/28/21 04:10:44 AM
#3509   And indeed from an outsider's perspective, no they Spideyboy 04/28/21 03:01:36 AM
#3508   fda updated page for today does not show midastouch017 04/28/21 01:31:54 AM
#3507   What strikes me as strange is the reply midastouch017 04/28/21 01:23:06 AM
#3506   the saver may be that slgl did not 1hb 04/27/21 06:04:12 PM
#3505   If you're right, it could be a great skitahoe 04/27/21 03:53:11 PM
#3504   Of course i hope to be wrong. I midastouch017 04/27/21 03:28:07 PM
#3503   That PR would send the stock price plummeting. king oil 04/27/21 02:15:51 PM
PostSubject
Consent Preferences